Influenza A viruses with induced resistance to a new candidate antiviral drug were found to be impaired in cell culture and weakened in animals, according to a study by researchers in the Center for Translational Antiviral ...
Feb 6, 2024
0
48
Antimicrobial resistance is one of the biggest global threats to health, food security and development. This month, The Conversation's experts explore how we got here and the potential solutions.
Nov 24, 2023
0
0
While conventional flu vaccines are designed to anticipate the influenza strains projected to dominate in the next flu season, they're only partially effective. And while antiviral drugs are available to treat active flu ...
Aug 15, 2023
0
89
Just as bacteria can develop antibiotic resistance, viruses can also evade drug treatments. Developing therapies against these microbes is difficult because viruses often mutate or hide themselves within cells. But by mimicking ...
Aug 2, 2023
0
1
Salk Institute researchers, in collaboration with the National Institutes of Health, have discovered the molecular mechanisms by which the human immunodeficiency virus (HIV) becomes resistant to Dolutegravir, one of the most ...
Jul 21, 2023
0
11
An antiviral drug used to treat SARS-CoV-2 remains effective against the newest variants of the evolving virus, according to Rutgers researchers.
Mar 18, 2022
0
121
Hepatitis C virus (HCV) is a hepatotropic virus, with about 80 million chronic infections confirmed worldwide. HCV infection leads to the development of chronic hepatitis, cirrhosis, and in some instances, hepatocellular ...
Apr 10, 2019
0
0
Antiviral drug resistance has long been a problem in modern society. As viruses evolve, they develop resistance to antiviral drugs, which become less effective at treating diseases such as influenza.
Aug 24, 2017
0
0
Research from UW Medicine and collaborators indicates that a drug-like molecule can activate innate immunity and induce genes to control infection in a range of RNA viruses, including West Nile, dengue, hepatitis C, influenza ...
Dec 17, 2015
0
10
A mechanism that enables the development of resistance to Acute Myeloid Leukemia (AML) anticancer drugs, thereby leading to relapse, has been identified by Kathy Borden of the University of Montreal's Institute for Research ...
May 28, 2014
0
0
